Navigation Links
CVS Caremark Donates Over $750,000 to The One Fund Boston
Date:5/14/2013

WOONSOCKET, R.I., May 14, 2013 /PRNewswire/ -- CVS Caremark announced today that a month-long, in-store fundraising campaign at CVS/pharmacy locations throughout Greater Boston raised over $650,000 in donations from customers to The One Fund Boston, which was established by Massachusetts Governor Deval Patrick and Boston Mayor Thomas Menino to raise money for victims and families who were affected by the attack on the Boston Marathon.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )

The in-store donation campaign at more than 260 Boston-area CVS/pharmacy stores ran from April 19 to May 11, during which customers could add $1, $3 or an amount of their choice to their purchase at the register. This fundraising follows a $100,000 donation to The One Fund Boston made by the CVS Caremark Charitable Trust, the private foundation of CVS Caremark.   

"We sincerely thank all of our Boston customers who supported our in-store campaign for The One Fund Boston and generously made a donation to help victims and families recover from this tragedy," said Larry Merlo , President and CEO of CVS Caremark. "I also want to thank our colleagues who responded quickly to launch this fundraising campaign within a few days of the Boston Marathon."

The One Fund Boston continues to accept online donations from the public at www.onefundboston.org.  

About the CVS Caremark Charitable Trust
The CVS Caremark Charitable Trust, Inc. is a private foundation created by CVS Caremark Corporation (NYSE: CVS). CVS Caremark is the largest pharmacy health care provider in the nation. The Trust's mission is to provide funding for health care, education and community involvement initiatives in CVS Caremark communities. General information about CVS Caremark is available through the Investor Relations portion of the Company's Web site at http://info.cvscaremark.com/investors or through the Web site's newsroom at http://info.cvscaremark.com/newsroom

About CVS/pharmacy
CVS/pharmacy, the retail division of CVS Caremark Corporation (NYSE: CVS), is America's leading retail pharmacy with more than 7,400 CVS/pharmacy and Longs Drug stores. CVS/pharmacy is reinventing pharmacy to help people on their path to better health by providing the most accessible and personalized expertise, both in its stores and online at CVS.com. General information about CVS/pharmacy and CVS Caremark is available at http://info.cvscaremark.com.

MEDIA CONTACT:
Mike DeAngelis
michael.deangelis@cvscaremark.com
401.770.2645 


'/>"/>
SOURCE CVS Caremark
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark Reports Strong First Quarter Results
2. CVS Caremark Offers Advice on Proper Management, Storage and Disposal of Medications in Light of New Study on Teen Abuse of Prescription Drugs
3. Cardinal Health Will Continue To Supply Pharmaceuticals To CVS Caremark Corporation
4. CVS Caremark Industry-Leading Generic Dispensing Rate Reduces Client Traditional Drug Spend by 3.6 Percent for 2012
5. CVS Caremark Charitable Trust Supports Non-profits Nationwide with $2.6 Million in Funding
6. CVS Caremark Research Finds Medication Adherence Can Improve Outcomes and Reduce Costs for Patients with Coronary Artery Disease
7. CVS Caremark MinuteClinic President Discusses Primary Care Innovation at London Healthcare Conferences
8. CVS Caremark Emphasizes Commitment to Older Americans at Annual American Society on Aging Conference
9. Accordant Health Services, a CVS Caremark Company, Receives URAC Case Management Accreditation
10. CVS Caremark CEO Addresses Economic Club of Pittsburgh on Reinventing Pharmacy for Better Health
11. CVS Caremark Appoints New Chief Digital Officer to Lead Digital Innovation Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):